229 related articles for article (PubMed ID: 15723037)
1. Modulation of human nuclear receptor LRH-1 activity by phospholipids and SHP.
Ortlund EA; Lee Y; Solomon IH; Hager JM; Safi R; Choi Y; Guan Z; Tripathy A; Raetz CR; McDonnell DP; Moore DD; Redinbo MR
Nat Struct Mol Biol; 2005 Apr; 12(4):357-63. PubMed ID: 15723037
[TBL] [Abstract][Full Text] [Related]
2. Crystal structure of the human LRH-1 DBD-DNA complex reveals Ftz-F1 domain positioning is required for receptor activity.
Solomon IH; Hager JM; Safi R; McDonnell DP; Redinbo MR; Ortlund EA
J Mol Biol; 2005 Dec; 354(5):1091-102. PubMed ID: 16289203
[TBL] [Abstract][Full Text] [Related]
3. Molecular dynamics simulations of human LRH-1: the impact of ligand binding in a constitutively active nuclear receptor.
Burendahl S; Treuter E; Nilsson L
Biochemistry; 2008 May; 47(18):5205-15. PubMed ID: 18410128
[TBL] [Abstract][Full Text] [Related]
4. Structural basis for antagonist-mediated recruitment of nuclear co-repressors by PPARalpha.
Xu HE; Stanley TB; Montana VG; Lambert MH; Shearer BG; Cobb JE; McKee DD; Galardi CM; Plunket KD; Nolte RT; Parks DJ; Moore JT; Kliewer SA; Willson TM; Stimmel JB
Nature; 2002 Feb; 415(6873):813-7. PubMed ID: 11845213
[TBL] [Abstract][Full Text] [Related]
5. Molecular mechanism for the potentiation of the transcriptional activity of human liver receptor homolog 1 by steroid receptor coactivator-1.
Xu PL; Liu YQ; Shan SF; Kong YY; Zhou Q; Li M; Ding JP; Xie YH; Wang Y
Mol Endocrinol; 2004 Aug; 18(8):1887-905. PubMed ID: 15143151
[TBL] [Abstract][Full Text] [Related]
6. Metal-dependent folding and stability of nuclear hormone receptor DNA-binding domains.
Low LY; Hernández H; Robinson CV; O'Brien R; Grossmann JG; Ladbury JE; Luisi B
J Mol Biol; 2002 May; 319(1):87-106. PubMed ID: 12051939
[TBL] [Abstract][Full Text] [Related]
7. Molecular dynamics simulation study for LRH-1: interaction with fragments of SHP and function of phospholipid ligand.
Zhang T; Zhou JH; Shi LW; Zhu RX; Chen MB
Proteins; 2008 Mar; 70(4):1527-39. PubMed ID: 17910058
[TBL] [Abstract][Full Text] [Related]
8. Over-expression and purification of isotopically labeled recombinant ligand-binding domain of orphan nuclear receptor human B1-binding factor/human liver receptor homologue 1 for NMR studies.
Chen X; Tong X; Xie Y; Wang Y; Ma J; Gao D; Wu H; Chen H
Protein Expr Purif; 2006 Jan; 45(1):99-106. PubMed ID: 16039139
[TBL] [Abstract][Full Text] [Related]
9. Expression, purification, and initial structural characterization of rat orphan nuclear receptor NOR-1 LBD domain.
Razzera G; Vernal J; Portugal RV; Calgaro MR; Fernandez P; Zakin MM; Polikarpov I; Terenzi H
Protein Expr Purif; 2004 Oct; 37(2):443-9. PubMed ID: 15358368
[TBL] [Abstract][Full Text] [Related]
10. Divergent sequence tunes ligand sensitivity in phospholipid-regulated hormone receptors.
Musille PM; Pathak M; Lauer JL; Griffin PR; Ortlund EA
J Biol Chem; 2013 Jul; 288(28):20702-12. PubMed ID: 23737522
[TBL] [Abstract][Full Text] [Related]
11. LRH-1: an orphan nuclear receptor involved in development, metabolism and steroidogenesis.
Fayard E; Auwerx J; Schoonjans K
Trends Cell Biol; 2004 May; 14(5):250-60. PubMed ID: 15130581
[TBL] [Abstract][Full Text] [Related]
12. The coactivator LXXLL nuclear receptor recognition motif.
Savkur RS; Burris TP
J Pept Res; 2004 Mar; 63(3):207-12. PubMed ID: 15049832
[TBL] [Abstract][Full Text] [Related]
13. Unveiling hidden features of orphan nuclear receptors: the case of the small heterodimer partner (SHP).
Macchiarulo A; Rizzo G; Costantino G; Fiorucci S; Pellicciari R
J Mol Graph Model; 2006 Mar; 24(5):362-72. PubMed ID: 16288980
[TBL] [Abstract][Full Text] [Related]
14. Conformational adaptation of nuclear receptor ligand binding domains to agonists: potential for novel approaches to ligand design.
Togashi M; Borngraeber S; Sandler B; Fletterick RJ; Webb P; Baxter JD
J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):127-37. PubMed ID: 15860255
[TBL] [Abstract][Full Text] [Related]
15. Found in the crystal: phospholipid ligands for nuclear orphan receptors.
Balla T
Trends Endocrinol Metab; 2005 Sep; 16(7):289-90. PubMed ID: 16054837
[TBL] [Abstract][Full Text] [Related]
16. Structure and function of the atypical orphan nuclear receptor small heterodimer partner.
Lee YS; Chanda D; Sim J; Park YY; Choi HS
Int Rev Cytol; 2007; 261():117-58. PubMed ID: 17560281
[TBL] [Abstract][Full Text] [Related]
17. Orphan nuclear receptors adopted by crystallography.
Ingraham HA; Redinbo MR
Curr Opin Struct Biol; 2005 Dec; 15(6):708-15. PubMed ID: 16263271
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the Nurr1 ligand-binding domain co-activator interaction surface.
Volakakis N; Malewicz M; Kadkhodai B; Perlmann T; Benoit G
J Mol Endocrinol; 2006 Oct; 37(2):317-26. PubMed ID: 17032747
[TBL] [Abstract][Full Text] [Related]
19. Synergistic regulation of the mouse orphan nuclear receptor SHP gene promoter by CLOCK-BMAL1 and LRH-1.
Oiwa A; Kakizawa T; Miyamoto T; Yamashita K; Jiang W; Takeda T; Suzuki S; Hashizume K
Biochem Biophys Res Commun; 2007 Feb; 353(4):895-901. PubMed ID: 17204240
[TBL] [Abstract][Full Text] [Related]
20. Orphan nuclear receptor SHP interacts with and represses hepatocyte nuclear factor-6 (HNF-6) transactivation.
Lee YS; Kim DK; Kim YD; Park KC; Shong M; Seong HA; Ha HJ; Choi HS
Biochem J; 2008 Aug; 413(3):559-69. PubMed ID: 18459945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
